These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8677896)

  • 21. [Prevention of ischemic and reperfusion arrhythmias using the calmodulin blocker trifluoperazine].
    Meerson FZ; Malyshev IIu; Larionov NP; Karpov RS
    Kardiologiia; 1988 May; 28(5):91-5. PubMed ID: 3411868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs.
    Elharrar V; Gaum WE; Zipes DP
    Am J Cardiol; 1977 Apr; 39(4):544-9. PubMed ID: 848439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic consequences of newer studies addressing the problem of myocardial ischemia and ventricular arrhythmias.
    Kuck KH; Siebels J; Schneider MA
    Herz; 1995 Jun; 20(3):213-8. PubMed ID: 7635402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
    Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
    Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-arrhythmic agents in ischemic heart disease: supraventricular arrhythmias, digitalis toxicity and chronic stable ventricular ectopic beats.
    Opie LH
    Methods Find Exp Clin Pharmacol; 1982; 4(1):25-35. PubMed ID: 7087606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog.
    Lynch JJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):193-203. PubMed ID: 2452314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
    Brogden RN; Benfield P
    Drugs; 1996 May; 51(5):792-819. PubMed ID: 8861548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of ischemic related ventricular tachycardia by verapamil during treadmill exercise testing.
    Brodsky SJ; Cutler SS; Weiner DA; Klein MD
    Chest; 1982 Jul; 82(1):111-3. PubMed ID: 7083917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-arrhythmic effect of verapamil is accompanied by preservation of cx43 protein in rat heart.
    Zhou P; Zhang SM; Wang QL; Wu Q; Chen M; Pei JM
    PLoS One; 2013; 8(8):e71567. PubMed ID: 23951191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
    Gülker H; Thale J; Brisse B; Bender F
    Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of verapamil in suppositories for treating patients with ischemic heart disease].
    Shkliar MB; Soleĭko MB; Alekseeva IP; Kul'chevich LV
    Vrach Delo; 1990 Aug; (8):13-5. PubMed ID: 2256273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of zatebradine, a specific bradycardic agent, on ischemia-induced arrhythmias in anesthetized rabbits.
    Bril A; Forest MC; Cheval B; Landais L; Gout B
    Pharmacology; 1994 May; 48(5):308-19. PubMed ID: 8016191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists. Clinical use in the treatment of arrhythmias.
    Singh BN; Nademanee K; Baky SH
    Drugs; 1983 Feb; 25(2):125-53. PubMed ID: 6339197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction.
    Hansen JF; Tingsted L; Rasmussen V; Madsen JK; Jespersen CM
    Am J Cardiol; 1996 Jun; 77(16):16D-21D. PubMed ID: 8677892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verapamil in cardiac arrhythmias: an overview.
    Vohra J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug effects on myocardial ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
    Huang TF; Huang LL
    Proc Natl Sci Counc Repub China B; 1991 Apr; 15(2):80-5. PubMed ID: 1946822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-ischemic therapy with verapamil. Improving prognosis by secondary prevention after acute myocardial infarct].
    Dotzer F; Gromer H
    Fortschr Med; 1993 May; 111(14):245-8. PubMed ID: 8335304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.